ロード中...
The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma
Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) is the standard first-line therapy for metastatic lung adenocarcinoma harboring sensitive EGFR mutations. Tumor surface programmed death-ligand 1 (PD-L1) is expressed in some metastatic EGFR-mutated lung adenocarcinoma, but its...
保存先:
| 出版年: | Biomedicines |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7167989/ https://ncbi.nlm.nih.gov/pubmed/32092879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines8020036 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|